Embryonic Stem Cell Research And Current Use - 1769 Words

Introduction: The issue at discussion in this report is ESCR (embryonic stem cell research) and current use. This issue causes controversial concerns because the first isolation of the embryo was in 1998, which is still very recent and the policies around it are grey areas. Many countries including the United States of America have removed funding because of issues that have risen due to religious, ethical and legal formalities. Some of the benefits that ESC (embryonic stem cells) promise are the cure for many diseases and even the creation of organs between other scientific advances that could save numerous lives. The benefits that ESC could provide are sometimes questioned to be worth all the ethical issues that they bring. Some†¦show more content†¦The process to isolate an embryonic cell demands de inner cell of a blastocyst. A blastocyst can be described as one of the earlier stages of an embryo, which is reached at about four to five days after fertilization. In the blastocyst stage , the future embryo is not formed by more than fifty to a 150 cells. In the blastocyst stage the cell is comprised of an external layer called trophoblast and the inner cell mass comprised of approximately thirty cells which following normal procedures becomes the embryo and the trophoblast, the placenta. In the process to cultivate the stem cell, the blastocyst must die as the inner cell mass is removed. This practice has been legalized since 2002 in Australia but strict guidelines in regards to licenses as to who is able to perform research and what is permitted in their research must be met. Alternative Views and their Explanation: Dr. James Douglas professor and chair, cell and developmental biology director for Center of Organogenesis has specialised and dedicated most of his career to research how tissues and organs are generated in mammals and how cells are instructed to become specialised cells. Similarly, Dr. Eva L. Feldman professor of neurology in the medical school ‘A. Alfred Taubman Medical Research Institute’ and director at ALS clinic has devoted her latest years in the field to conduct innovative research to generate stem-cell technology to treat ALS by injecting stem cells into the spinal cord.